Ursprung des Netzwerks ersten Grades von Carlo Saetti
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Opocrin SpA
Opocrin SpA Pharmaceuticals: MajorHealth Technology Opocrin SpA engages in the manufacture and marketing of active ingredients for the pharmaceutical industry. Its products include Collagen Gel, Sodium and Calcium Heparin, Iron Complexes, Parnaparin, and Pulmonary Surfactant. The company was founded by Pietro Bianchini in 1964 and is headquartered in Modena, Italy.
6
| Private Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Carlo Saetti
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi Hellas Pharmaceuticals SA
Chiesi Hellas Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Chiesi Hellas Pharmaceuticals SA provides research, development and sale of medicinal products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It offers solutions for the treatment of asthma and chronic obstructive pulmonary disease. The company is headquartered in Vrilissa, Greece. | Pharmaceuticals: Major | Director/Board Member | |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Pharmaceuticals: Major | General Counsel | |
CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Parma | College/University | Graduate Degree | |
Cheshire Healthcare Ltd. | Director/Board Member | ||
Chiesi Ltd.
Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Chiesi Healthcare Ltd. | Director/Board Member | ||
Chiesi SAS
Chiesi SAS Pharmaceuticals: GenericHealth Technology Chiesi SAS wholesales and distributes pharmaceutical products. The company was founded in 1992 and is headquartered in Bois-Colombes, France. | Pharmaceuticals: Generic | Director/Board Member | |
Chiesi International Holding BV | Director/Board Member | ||
Levant Capital | Director/Board Member | ||
Chiesi Pharmaceuticals BV
Chiesi Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Chiesi Pharmaceuticals BV provides research, development and sale of medical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation and neonatology. The company is headquartered in Rijswijk, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Opocrin SRL | Director/Board Member | ||
Novadynamics Healthcare SRL | Director/Board Member | ||
Chiesi Pharmaceuticals (Pvt) Ltd. | Director/Board Member | ||
Chiesi Pharmaceuticals, Inc. | Director/Board Member | ||
Chiesi España SA
Chiesi España SA Pharmaceuticals: MajorHealth Technology Chiesi España SA manufactures and distributes pharmaceutical products. It offers solutions for therapeutic areas such as respiratory, cardiovascular, musculoskeletal, inflammation, and neonatology. The firm produces respiratory dosage forms such as metered-dose inhalers and sterile unit dose vials for nebulisation. It also provides solutions for the treatment of asthma and chronic obstructive pulmonary diseases. The company is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Chiesi Pharmaceuticals Shanghai Co. Ltd. | Director/Board Member | ||
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Pharmaceuticals: Major | Director/Board Member | |
Vandel Group Jlt | Director/Board Member | ||
Bacara Holdings Ltd.
Bacara Holdings Ltd. Industrial MachineryProducer Manufacturing Bacara Holdings Ltd. manufactures weaving machines. The private company is based in Limassol, Cyprus. | Industrial Machinery | Director/Board Member | |
Advent International LP
Advent International LP Investment ManagersFinance Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Spear Therapeutics Ltd.
Spear Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
Hunter-Fleming Ltd.
Hunter-Fleming Ltd. Pharmaceuticals: MajorHealth Technology Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
University of Denver | College/University | Undergraduate Degree | |
TVM Capital GmbH
TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Investor | |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Director/Board Member | |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | Specialty Stores | Founder | |
Bacara SA | Director/Board Member | ||
Cerus Advisors DMCC
Cerus Advisors DMCC Investment ManagersFinance Cerus Advisors DMCC (Cerus) is a private equity firm founded in 2015. The firm is headquartered in Dubai with additional offices in UAE and in La Jolla, California, United States. | Investment Managers | Chairman | |
IRRAS AB | Medical Specialties | Chairman | |
Vandel Group LLC | Chief Executive Officer | ||
Mediolanum Farmaceutici SpA
Mediolanum Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Mediolanum Farmaceutici SpA engages in the manufacture and distribution of pharmaceutical and therapeutic medicines. Its products include Antoven, Adronat, Budexan, Cechio, and Genalen. The firm provides medical research and development programs. The company was founded by Rinaldo del Bono in 1972 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Plastics Unbound Ltd. | Director/Board Member | ||
Klaris SA
Klaris SA Pharmaceuticals: MajorHealth Technology Klaris SA is a Luxembourger company that manufactures and distributes pharmaceutical products. The private company is based in Luxembourg, Luxembourg. | Pharmaceuticals: Major | Director/Board Member | |
Shoreline Biosciences, Inc.
Shoreline Biosciences, Inc. BiotechnologyHealth Technology Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA. | Biotechnology | Founder | |
Lexington Holding Assets Ltd.
Lexington Holding Assets Ltd. Financial ConglomeratesFinance Lexington Holding Assets Ltd. functions as an investment holding There is no available country named vg company. The private company is based in Road Town, British Virgin Islands. | Financial Conglomerates | Director/Board Member | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 14 |
Vereinigtes Königreich | 7 |
Italien | 6 |
Vereinigte Arabische Emirate | 4 |
Niederlande | 3 |
Sektoral
Health Technology | 17 |
Finance | 7 |
Consumer Services | 4 |
Electronic Technology | 2 |
Producer Manufacturing | 2 |
Operativ
Director/Board Member | 34 |
Private Equity Investor | 5 |
Independent Dir/Board Member | 3 |
Chairman | 3 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Marios Fotiadis | 25 |
Marco Vecchia | 19 |
Luigi Zuppello | 1 |
Sandra Cioni | 1 |
Federico Saetti | 1 |
Mara Bianchini | 1 |
- Börse
- Insiders
- Carlo Saetti
- Unternehmensverbindungen